(A): Median progression‐free survival was 1.6 months (95% CI: 1.0, 4.1) versus 1.1 months (0.9, 2.7; p = .92) for absent versus present HFSR. (B): Median overall survival was 6.9 months (95% CI: 4.8, 10.6) versus 8.8 months (6.3, 11.3; p = .67) for absent and present HFSR, respectively. Abbreviations: CI, confidence interval; HFSR, hand‐foot skin reaction; HR, hazard ratio; KM, Kaplan‐Meier.